Home/Pipeline/Spine Implants

Spine Implants

Spinal Fusion

CommercialActive

Key Facts

Indication

Spinal Fusion

Phase

Commercial

Status

Active

Company

OsteoCentric Technologies

About OsteoCentric Technologies

OsteoCentric Technologies is pioneering a mechanical approach to the implant-bone interface with its patented UnifiMI technology. Unlike traditional compressive implants that damage bone, UnifiMI's unique thread geometry aims to interlock with and preserve bone structure, providing instant stability and load-sharing. The technology is commercialized across multiple segments including spine, trauma, and dental, and is reportedly used in over 100 Level 1 trauma centers. The company's vision is to eliminate the post-operative 'stability dip' common with conventional implants, thereby improving healing timelines and outcomes.

View full company profile

Therapeutic Areas

Orthopedics Dental Veterinary

Other Spinal Fusion Drugs

Drug	Company	Phase	Status
JAZBI™ Cubes	SDIP Innovations	Preclinical	Active
Expandable Interbody Portfolio	Globus Medical	Iterative Development	Active
Mimetic Metal Technology Development	CoreLink Surgical	Development/Commercial	Active
Bone Graft Substitute	BiologicsMD	Pre-clinical	Active
VisuALIF	SpineSmith	Commercial	Active
ASTRO Registry	Artoss	Post-Market	Active
Hive Smart Implant Exploration	NanoHive Medical	Pre-clinical R&D	Active
ProLift Pivot Expandable Spacer System	Life Spine	FDA Cleared	Active
NEXXT MATRIXX Clinical Evidence Study	Nexxt Spine	Post-Market Study	Active
AGA111	Angitia Biopharmaceuticals	Phase 3	Active
X-PAC® Portfolio Expansion	Expanding Innovations	Development	Active
SOLACE™	Xenix Medical	Commercial	Active